Catalog Home Page

Publications: Kermode, Allan

Stats for Kermode, Allan
Export as [feed] RSS
Group by: Publication Type | Year
Number of items: 189.

Journal Article

Zhou, Y., Zhong, X., Shu, Y., Cui, C., Wang, J., Wang, Y., Li, X., Chen, Z., Peng, L., Kermode, A. and Qiu, W. (2019) Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders, 28 . pp. 213-220.

Triplett, J., Vijayan, S., Prince, R. and Kermode, A. (2019) Dimethyl fumarate–associated transient bone marrow oedema syndrome. Multiple Sclerosis Journal, 25 (6). pp. 876-879.

Joshi, S. and Kermode, A.G. (2019) Harding’s disease: an important MS mimic. BMJ Case Reports, 12 (3).

Zhong, X., Zhou, Y., Chang, Y., Wang, J., Shu, Y., Sun, X., Peng, L., Lau, A.Y., Kermode, A.G. and Qiu, W. (2019) Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of Chinese patients. Frontiers in Neurology, 10 .

Zhong, X.N., Zhou, Y.F., Chang, Y.Y., Wang, J.Q., Shu, Y.Q., Sun, X.B., Peng, L.S., Lau, A.Y., Kermode, A.G. and Qiu, W. (2019) Seizures in Chinese Patients with Myelin Oligodendrocyte Glycoprotein Encephalomyelitis: A retrospective study in single center. Multiple Sclerosis Journal, 25 (3). p. 481.

Shu, Y., Zhang, L., Chang, Y., Li, R., Sun, X., Li, J., Wu, H., Yang, Y., Peng, L., Lu, Z., Kermode, A.G. and Qiu, W. (2018) Association of serum Cystatin C with neuromyelitis optica spectrum disorders. European Journal of Neurology, 25 (7). pp. 999-1002.

Lu, T.T., Shu, Y.Q., Dai, Y.Q., Liu, X., Chang, Y.Y., Huang, Q., Kermode, A. and Qui, W. (2018) B Cell Depleting Therapy for Multiple Sclerosis Overlapping with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal, 24 (3). p. 420.

Lu, T., Shu, Y., Dai, Y., Liu, X., Chang, Y., Huang, Q., Kermode, A.G. and Qiu, W. (2018) B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders, 22 . pp. 83-85.

Shu, Y., Long, Y., Chang, Y., Li, R., Sun, X., Wang, Y., Huang, Y., Li, J., Chen, J., Yang, Y., Lu, Z., Hu, X., Kermode, A.G. and Qiu, W. (2018) Brain immunohistopathology in a patient with autoimmune Glial Fibrillary acidic protein astrocytopathy. Neuroimmunomodulation . In Press.

Kermode, A.G. and Triplett, J.D. (2018) Chronic HPV associated lesions associated with Fingolimod use. Multiple Sclerosis Journal, 25 (3). pp. 460-461.

Chang, Y.Y., Shu, Y.Q., Sun, X.B., Xu, C.F., He, D., Fang, L., Chen, C., Hu, X.Q., Kermode, A. and Wei, Q. (2018) Ectrodactyly in A Chinese Patient Born to A Mother with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal, 24 (3). pp. 418-419.

Chang, Y., Shu, Y., Sun, X., Xu, C., He, D., Fang, L., Chen, C., Hu, X., Kermode, A. and Qiu, W. (2018) Ectrodactyly in a Chinese patient born to a mother with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders, 19 . pp. 70-72.

Fabis-Pedrini, M.J., Carroll, W.M. and Kermode, A.G. (2018) Efficacy and safety of mitoxantrone use in aggressive Multiple Sclerosis (P3.414). Neurology, 90 (15 Supp).

Trend, S., Jones, A.P., Cha, L., Byrne, S.N., Geldenhuys, S., Fabis-Pedrini, M.J., Carroll, W.M., Cole, J.M., Booth, D.R., Lucas, R.M., Kermode, A.G., French, M.A. and Hart, P.H. (2018) Higher serum immunoglobulin G3 levels may predict the development of multiple sclerosis in individuals with Clinically Isolated Syndrome. Frontiers in Immunology, 9 .

Fabis-Pedrini, M.J., Bundell, C., Wee, C.K., Qui, W., Lucas, M., Carroll, W.M. and Kermode, A.G. (2018) Low Prevalence of Anti Aquaporin 4 Antibody in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Western Australia. Multiple Sclerosis Journal, 24 (3). pp. 404-405.

Kermode, A. (2018) The Microbiota and MS. Multiple Sclerosis Journal, 24 (3). p. 368.

Zhou, Y., Jia, X., Yang, H., Chen, C., Sun, X., Peng, L., Kermode, A.G. and Qiu, W. (2018) Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes. European Journal of Neurology, 26 (1). pp. 175-183.

Kermode, A.G., Hart, P.H., Fabis-Pedrini, M.J., Lucas, R.M., Booth, D.R., Carroll, W.M., Nolan, D., Cole, J.M., Jones, A.P. and Trend, S. (2018) Narrowband UVB Phototherapy for Clinically Isolated Syndrome: Delivering the Benefits of All UVB-Induced Molecules. Multiple Sclerosis Journal, 24 (3). pp. 376-377.

Fabis-Pedrini, M.J., James, I., Seewann, A., Yau, W.Y., van de Bovenkamp, A.A., Sanders, F.R.K., Qiu, W., Burton, J., Mastaglia, F.L., Carroll, W.M. and Kermode, A.G. (2018) Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort. Journal of the Neurological Sciences, 388 . pp. 12-18.

Fabis-Pedrini, M.J., Bundell, C., Wee, C-K, Lucas, M., McLean-Tooke, A., Mastaglia, F.L., Carroll, W.M. and Kermode, A.G. (2018) Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia. Journal of Neuroimmunology, 324 . pp. 76-80.

Zhong, X., Chang, Y., Tan, S., Wang, J., Sun, X., Wu, A., Peng, L., Lau, A.Y., Kermode, A.G. and Qiu, W. (2018) Relapsing optic neuritis and meningoencephalitis in a Child-Delayed diagnosis of MOG-IgG syndrome. Multiple Sclerosis Journal, 25 (3). p. 490.

Fabis-Pedrini, M.J., Jeereddy, S., Carroll, W.M. and Kermode, A.G. (2018) Serum Anti-JCV antibody status in Western Australian patients with multiple sclerosis. Multiple Sclerosis Journal, 25 (3). p. 450.

Li, R., Sun, X., Shu, Y., Wang, Y., Xiao, L., Wang, Z., Hu, X., Kermode, A.G. and Qui, W. (2018) Serum CCL20 and Its Association with SIRT1 Activity in Multiple Sclerosis Patients. Multiple Sclerosis Journal, 24 (3). p. 390.

Chang, Y.Y., Shu, Y.Q., Sun, X.B., Lu, T.T., Chen, C., Fang, L., He, D., Xu, C.F., Lu, Z.Q., Hu, H.Q., Peng, L.S., Kermode, A.G. and Qui, W. (2018) Study of The Placentae of Patients with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal, 24 (3). p. 409.

Chang, Y., Shu, Y., Sun, X., Lu, T., Chen, C., Fang, L., He, D., Xu, C., Lu, Z., Hu, X., Peng, L., Kermode, A.G. and Qiu, W. (2018) Study of the placentae of patients with neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences, 387 . pp. 119-123.

Kermode, A.G., Triplett, J.D., Vijayan, S. and Prince, R. (2018) Transient bone marrow oedema syndrome following Dimethyl Fumarate use. Multiple Sclerosis Journal, 25 (3). p. 458.

Cha, L., Jones, A.P., Trend, S., Byrne, S.N., Fabis-Pedrini, M.J., Carroll, W.M., Lucas, R.M., Cole, J.M., Booth, D.R., Kermode, A.G. and Hart, P.H. (2018) Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis. Clinical & Translational Immunology, 7 (8).

Ghaly, S., Bliuc, D., Centre, J., Clarke, M.W., Jones, A.P., Trend, S., Kermode, A.G., Neale, R.E. and Hart, P.H. (2018) Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans. The Journal of Steroid Biochemistry and Molecular Biology, 186 . pp. 110-116.

Triplett, J., Kermode, A.G., Corbett, A. and Reddel, S.W. (2018) Warts and all: Fingolimod and unusual HPV-associated lesions. Multiple Sclerosis Journal . Online First.

Hart, P.H., Jones, A.P., Trend, S., Cha, L., Fabis-Pedrini, M.J., Cooper, M.N., d’Este, C., Geldenhuys, S., Carroll, W.M., Byrne, S.N., Booth, D.R., Cole, J.M., Lucas, R.M. and Kermode, A.G. (2018) A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 4 (2).

Trend, S., Jones, A., Geldenhuys, S., Byrne, S., Fabis-Pedrini, M., Nolan, D., Booth, D., Carroll, W., Lucas, R., Kermode, A.G. and Hart, P. (2017) Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI. International Journal of Molecular Sciences, 18 (6). p. 1277.

Jones, A.P., Trend, S., Byrne, S.N., Fabis-Pedrini, M.J., Geldenhuys, S., Nolan, D., Booth, D.R., Carroll, W.M., Lucas, R.M., Kermode, A.G. and Hart, P.H. (2017) Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: Clues to the development of multiple sclerosis. Clinical & Translational Immunology, 6 (5).

Shu, Y., Li, R., Qiu, W., Chang, Y., Sun, X., Fang, L., Chen, C., Yang, Y., Lu, Z., Hu, X. and Kermode, A.G. (2017) Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Multiple Sclerosis and Related Disorders, 18 . pp. 65-70.

Zhou, Y., Huang, Q., Lu, T., Sun, X., Fang, L., Lu, Z., Hu, X., Kermode, A. and Qiu, W. (2017) Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG. Journal of Clinical Neuroscience, 38 . pp. 71-73.

Joshi, S., Yau, W. and Kermode, A. (2017) CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags. Journal of Clinical Neuroscience, 35 . pp. 75-77.

Kalincik, T., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Lechner-Scott, J., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Solaro, C., Grand’Maison, F., Hupperts, R., Prevost, J., Sola, P., Ferraro, D., Terzi, M., Butler, E., Slee, M., Kermode, A., Fabis-Pedrini, M., McCombe, P., Barnett, M., Shaw, C., Hodgkinson, S. and Butzkueven, H. (2017) Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. Multiple Sclerosis Journal, 24 (12). pp. 1617-1626.

Stewart, T., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Prat, A., Lugaresi, A., Grand’Maison, F., Grammond, P., Sola, P., Shaygannejad, V., Hupperts, R., Alroughani, R., Oreja-Guevara, C., Pucci, E., Boz, C., Lechner-Scott, J., Bergamaschi, R., van Pesch, V., Iuliano, G., Ramo, C., Taylor, B., Slee, M., Spitaleri, D., Granella, F., Verheul, F., McCombe, P., Hodgkinson, S., Amato, M.P., Vucic, S., Gray, O., Cristiano, E., Barnett, M., Sanchez Menoyo, J.L., van Munster, E., Saladino, M.L., Olascoaga, J., Prevost, J., Deri, N., Shaw, C., Singhal, B., Moore, F., Rózsa, C., Shuey, N., Skibina, O., Kister, I., Petkovska-Boskova, T., Ampapa, R., Kermode, A., Butzkueven, H., Jokubaitis, V. and Kalincik, T. (2017) Contribution of different relapse phenotypes to disability in multiple sclerosis. Multiple Sclerosis Journal, 23 (2). pp. 266-276.

Fewings, N., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2017) Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis. Data in Brief, 11 . pp. 364-370.

Yau, W.Y., Fabis-Pedrini, M.J. and Kermode, A.G. (2017) Fabry heterozygote mimicking multiple sclerosis. BMJ Case Reports .

Bukhari, W., Prain, K.M., Waters, P., Woodhall, M., O‘Gorman, C.M., Clarke, L., Silvestrini, R.A., Bundell, C.S., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brown, M., Brownlee, W.J., Butzkueven, H., Carroll, W.M., Chen, C., Coulthard, A., Dale, R.C., Das, C., Dear, K., Fabis-Pedrini, M.J., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Jimenez-Sanchez, S., Killpatrick, T., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M., Lynch, C., Macdonell, R., Mason, D.F., McCombe, P.A., Pender, M.P., Pereira, J.A., Pollard, J.D., Reddel, S.W., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R.C., Yiu, E.M., Barnett, M.H., Kermode, A.G., Marriott, M.P., Parratt, J.D.E., Slee, M., Taylor, B.V., Willoughby, E., Wilson, R.J., Vincent, A. and Broadley, S.A. (2017) Incidence and prevalence of NMOSD in Australia and New Zealand. Journal of Neurology, Neurosurgery & Psychiatry, 88 (8). pp. 632-638.

Zhong, X., Zhou, Y., Lu, T., Wang, Z., Fang, L., Peng, L., Kermode, A.G. and Qiu, W. (2017) Infections in neuromyelitis optica spectrum disorder. Journal of Clinical Neuroscience, 47 . pp. 14-19.

Cull, G., Hall, D., Fabis-Pedrini, M.J., Carroll, W.M., Forster, L., Robins, F., Ghassemifar, R., Crosbie, C., Walters, S., James, I., Augustson, B. and Kermode, A.G. (2017) Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 3 (1). pp. 1-9.

Hart, P.H., Lucas, R.M., Booth, D.R., Carroll, W.M., Nolan, D., Cole, J.M., Jones, A.P. and Kermode, A.G. (2017) Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of Vitamin D and other UVB-Induced molecules. Frontiers in Immunology, 8 .

Kermode, A.G., Hart, P., Lucas, R., Booth, D., Carroll, W., Nolan, D., Cole, J., Jones, A. and Trend, S. (2017) Narrowband UVB phototherapy for clinically isolated syndrome: Delivering the benefits of all UVB-induced molecules. Journal of the Neurological Sciences, 381 (Supp.). p. 446.

Huang, Y., Wang, Y., Zhou, Y., Huang, Q., Sun, X., Chen, C., Fang, L., Long, Y., Yang, H., Wang, H., Li, C., Lu, Z., Hu, X., Kermode, A.G. and Qiu, W. (2017) Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China. Journal of the Neurological Sciences, 372 . pp. 152-156.

Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M., Jokubaitis, V.G., McKay, F.C., Gatt, P.N., Fabis-Pedrini, M.J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A.G., Slee, M., Taylor, B.V., Vandenbroeck, K., Comabella, M., Boneschi, F.M. and King, C. (2017) Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study. The Pharmacogenomics Journal, 17 (4). pp. 312-318.

Li, R., Sun, X., Shu, Y., Wang, Yuge, Xiao, Li, Wang, Z., Hu, X., Kermode, A.G. and Qiu, W. (2017) Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients. Journal of Neuroimmunology, 313 . pp. 56-60.

Fewings, N.L., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2017) The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis. Journal of Autoimmunity, 78 . pp. 57-69.

Yau, W.Y., Fabis-Pedrini, M.J. and Kermode, A.G. (2016) Acute reversible seronegative cerebellar ataxia in a young woman with ovarian teratoma. Journal of the Neurological Sciences, 369 . pp. 227-228.

Chu, L., Dai, Q., Xu, Z., He, D., Wang, H., Wang, Q., Zhang, Y., Zhu, Y., Li, Y., Cai, G., Krantic, S. and Kermode, A. (2016) Association between the single nucleotide polymorphism and the level of Aquaporin-4 protein expression in Han and minority Chinese with inflammatory demyelinating diseases of the central nervous system. Molecular Neurobiology, 53 (5). pp. 2878-2885.

Fabis-Pedrini, M.J., Xu, W., Burton, J., Carroll, W.M. and Kermode, A.G. (2016) Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment. Journal of Clinical Neuroscience, 25 . pp. 145-147.

Jones, A.P., Kermode, A.G., Lucas, R.M., Carroll, W.M., Nolan, D. and Hart, P.H. (2016) Circulating immune cells in multiple sclerosis. Clinical & Experimental Immunology, 187 (2). pp. 193-203.

Gibson, G., Binder, M.D., Fox, A.D., Merlo, D., Johnson, L.J., Giuffrida, L., Calvert, S.E., Akkermann, R., Ma, G.Z.M., Perera, A.A., Gresle, M.M., Laverick, L., Foo, G., Fabis-Pedrini, M.J., Spelman, T., Jordan, M.A., Baxter, A.G., Foote, S., Butzkueven, H., Kilpatrick, T.J., Field, J. and Kermode, A.G. (2016) Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status. PLoS Genetics, 12 (3).

Zhou, Y., Zhu, G., Charlesworth, J.C., Simpson, S., Rubicz, R., Göring, H.H.H., Patsopoulos, N.A., Laverty, C., Wu, F., Henders, A., Ellis, J.J., van der Mei, I., Montgomery, G.W., Blangero, J., Curran, J.E., Johnson, M.P., Martin, N.G., Nyholt, D.R., Taylor, B.V. and Kermode, A.G. (2016) Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis. Multiple Sclerosis Journal, 22 (13). pp. 1655-1664.

Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., James, I., Carroll, W.M., Kermode, A.G. and Nolan, D. (2016) Identifying Patient-Specific Epstein-Barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis. PloS one, 11 (2).

Dai, Y., Lu, T., Wang, Y., Fang, L., Li, R., Kermode, A.G. and Qiu, W. (2016) Rapid exacerbation of neuromyelitis optica after rituximab treatment. Journal of Clinical Neuroscience, 26 . pp. 168-170.

Lu, T.T., Dai, Y.Q., Wang, Y.G., Fang, L., Li, R., Kermode, A.G. and Qju, W. (2016) Rapid exacerbation of neuromyelitis optica after rituximab treatment. Multiple Sclerosis Journal, 22 (3). p. 440.

McKay, F.C., Gatt, P.N., Fewings, N., Parnell, G.P., Schibeci, S.D., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2016) The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies. Clinical Immunology, 163 . pp. 96-107.

Pedrini, M.J., Cull, G., Augustson, B.M., Walters, S., Crosbie, C., Carroll, W.M. and Kermode, A.G. (2015) Autologous stem cell transplantation in multiple sclerosis: Results from a single centre. Multiple Sclerosis Journal, 21 (6). p. 806.

Qiu, W., Kermode, A.G., Li, R., Dai, Y., Wang, Y., Wang, J., Zhong, X., Li, C., Lu, Z. and Hu, X. (2015) Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica. Journal of Clinical Neuroscience, 22 (7). pp. 1178-1182.

McKay, F., Gatt, P.N., Fewings, N., Schibeci, S.D., Parnell, G., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2015) Characterising the Molecular Phenotypes of MS: heredity, gene expression modules, dysregulated immune cell subsets and response to therapy. Multiple Sclerosis Journal, 21 (14). NP1-NP32.

Goris, A., Pauwels, I., Gustavsen, M.W., van Son, B., Hilven, K., Bos, S.D., Celius, E.G., Berg-Hansen, P., Aarseth, J., Myhr, K-M, D'Alfonso, S., Barizzone, N., Leone, M.A., Martinelli Boneschi, F., Sorosina, M., Liberatore, G., Kockum, I., Olsson, T., Hillert, J., Alfredsson, L., Bedri, S.K., Hemmer, B., Buck, D., Berthele, A., Knier, B., Biberacher, V., van Pesch, V., Sindic, C., Bang Oturai, A., Sondergaard, H.B., Sellebjerg, F., Jensen, P.E.H., Comabella, M., Montalban, X., Perez-Boza, J., Malhotra, S., Lechner-Scott, J., Broadley, S., Slee, M., Taylor, B., Kermode, A.G., Gourraud, P-A, Sawcer, S.J., Andreassen, B.K., Dubois, B. and Harbo, H.F. (2015) Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain, 138 (3). pp. 632-643.

Pedrini, M.J.F., Seewann, A., Bennett, K.A., Wood, A.J.T., James, I., Burton, J., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2015) Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females. Journal of Neurology, Neurosurgery & Psychiatry, 86 (6). pp. 603-607.

Field, J., Shahijanian, F., Schibeci, S., Johnson, L., Gresle, M., Laverick, L., Parnell, G., Stewart, G., McKay, F., Kilpatrick, T., Butzkueven, H., Booth, D. and Kermode, A. (2015) The MS risk allele of CD40 is associated with reduced Cell-membrane bound expression in antigen presenting cells: Implications for gene function. PLoS ONE, 10 (6).

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J.M., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2015) A new era in the treatment of multiple sclerosis. The Medical Journal of Australia, 203 (3). pp. 139-141.

Gu, B.J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T.J., Lechner-Scott, J., Scott, R., Lea, R., Taylor, B.V., Stankovich, J., Butzkueven, H., Gresle, M., Laws, S.M., Petrou, S., Hoffjan, S., Akkad, D.A., Graham, C.A., Hawkins, S., Glaser, A., Bedri, S.K., Hillert, J., Matute, C., Antigüedad, A., Wiley, J.S. and Kermode, A. (2015) A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. Human Molecular Genetics, 24 (19). pp. 5644-5654.

Shahijanian, F., Parnell, G.P., McKay, F.C., Gatt, P.N., Shojoei, M., O'Connor, K.S., Schibeci, S.D., Brilot, F., Liddle, C., Batten, M., Stewart, G.J., Booth, D.R. and Kermode, A.G. (2014) The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells. Human Molecular Genetics, 23 (6). pp. 1425-1434.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D., Pedrini, M., Kermode, A., Carroll, W. and Nolan, D. (2014) Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risks. Multiple Sclerosis Journal, 20 (3). pp. 286-294.

Goris, A., van Setten, J., Diekstra, F., Ripke, S., Patsopoulos, N.A., Sawcer, S.J., van Es, M., Andersen, P.M., Melki, J., Meininger, V., Hardiman, O., Landers, J.E., Brown, R.H., Shatunov, A., Leigh, N., Al-Chalabi, A., Shaw, C.E., Traynor, B.J., Chio, A., Restagno, G., Mora, G., Ophoff, R.A., Oksenberg, J.R., Van Damme, P., Compston, A., Robberecht, W., Dubois, B., van den Berg, L.H., De Jager, P.L., Veldink, J.H., de Bakker, P.I.W. and Kermode, A.G. (2014) No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Human Molecular Genetics, 23 (7). pp. 1916-1922.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, 21 (11). pp. 1835-1846.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience, 21 (11). pp. 1847-1856.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations. Journal of Clinical Neuroscience, 21 (11). pp. 1857-1865.

Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., Oturai, A., Saarela, J., Fontaine, B., Hemmer, B., Martin, C., Zipp, F., D'Alfonso, S., Martinelli-Boneschi, F., Taylor, B., Harbo, H.F., Kockum, I., Hillert, J., Olsson, T., Ban, M., Oksenberg, J.R., Hintzen, R., Barcellos, L.F., Agliardi, C., Alfredsson, L., Alizadeh, M., Anderson, C., Andrews, R., Søndergaard, H.B., Baker, A., Band, G., Baranzini, S.E., Barizzone, N., Barrett, J., Bellenguez, C., Bergamaschi, L., Bernardinelli, L., Berthele, A., Biberacher, V., Binder, T.M.C., Blackburn, H., Bomfim, I.L., Brambilla, P., Broadley, S., Brochet, B., Brundin, L., Buck, D., Butzkueven, H., Caillier, S.J., Camu, W., Carpentier, W., Cavalla, P., Celius, E.G., Coman, I., Comi, G., Corrado, L., Cosemans, L., Cournu-Rebeix, I., Cree, B.A.C., Cusi, D., Damotte, V., Defer, G., Delgado, S.R., Deloukas, P., di Sapio, A., Dilthey, A.T., Donnelly, P., Dubois, B., Duddy, M., Edkins, S., Elovaara, I., Esposito, F., Evangelou, N., Fiddes, B., Field, J., Franke, A., Freeman, C., Frohlich, I.Y., Galimberti, D., Gieger, C., Gourraud, P-A, Graetz, C., Graham, A., Grummel, V., Guaschino, C., Hadjixenofontos, A., Hakonarson, H., Halfpenny, C., Hall, G., Hall, P., Hamsten, A., Harley, J., Harrower, T., Hawkins, C., Hellenthal, G., Hillier, C., Hobart, J., Hoshi, M., Hunt, S.E., Jagodic, M., Jelčić, I., Jochim, A., Kendall, B., Kermode, A., Kilpatrick, T., Koivisto, K., Konidari, I., Korn, T., Kronsbein, H., Langford, C., Larsson, M., Lathrop, M., Lebrun-Frenay, C., Lechner-Scott, J., Lee, M.H., Leone, M.A., Leppä, V., Liberatore, G., Lie, B.A., Lill, C.M., Linden, M., Link, J., Luessi, F., Lycke, J., Macciardi, F., Männistö, S., Manrique, C.P., Martin, R., Martinelli, V., Mason, D., Mazibrada, G., McCabe, C., Mero, I-L, Mescheriakova, J., Moutsianas, L., Myhr, K-M, Nagels, G., Nicholas, R., Nilsson, P., Piehl, F., Pirinen, M., Price, S.E., Quach, H., Reunanen, M., Robberecht, W., Robertson, N.P., Rodegher, M., Rog, D., Salvetti, M., Schnetz-Boutaud, N.C., Sellebjerg, F., Selter, R.C., Schaefer, C., Shaunak, S., Shen, L., Shields, S., Siffrin, V., Slee, M., Sorensen, P.S., Sorosina, M., Sospedra, M., Spurkland, A., Strange, A., Sundqvist, E., Thijs, V., Thorpe, J., Ticca, A., Tienari, P., van Duijn, C., Visser, E.M., Vucic, S., Westerlind, H., Wiley, J.S., Wilkins, A., Wilson, J.F., Winkelmann, J., Zajicek, J., Zindler, E., Haines, J.L., Pericak-Vance, M.A., Ivinson, A.J., Stewart, G., Hafler, D., Hauser, S.L., Compston, A., McVean, G., De Jager, P., Sawcer, S.J. and McCauley, J.L. (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45 (11). pp. 1353-1360.

Zhang, L., Mechelli, R., Umeton, R., Policano, C., Annibali, V., Coarelli, G., Ricigliano, V.A.G., Vittori, D., Fornasiero, A., Buscarinu, M.C., Romano, S., Salvetti, M., Ristori, G. and Kermode, A.G. (2013) A “Candidate-Interactome” aggregate analysis of Genome-Wide association data in multiple sclerosis. PloS one, 8 (5). e63300.

Lee, S.H., Harold, D., Nyholt, D.R., Goddard, M.E., Zondervan, K.T., Williams, J., Montgomery, G.W., Wray, N.R., Visscher, P.M. and Kermode, A.G. (2013) Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Human Molecular Genetics, 22 (4). pp. 832-841.

Gibson, G., Patsopoulos, Nikolaos A., Barcellos, Lisa F., Hintzen, Rogier Q., Schaefer, Catherine, van Duijn, Cornelia M., Noble, Janelle A., Raj, Towfique, Gourraud, Pierre-Antoine, Stranger, Barbara E., Oksenberg, Jorge, Olsson, Tomas, Taylor, Bruce V., Sawcer, Stephen, Hafler, David A., Carrington, Mary, De Jager, Philip L., de Bakker, Paul I. W. and Kermode, A.G. (2013) Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects. PLoS Genetics, 9 (11). e1003926.

Xu, W., li, R., Dai, Y., Wu, A., Wang, H., Cheng, C., Qiu, W., Lu, Z., Zhong, X., Shu, Y., Kermode, A.G. and Hu, X. (2013) IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. Journal of Neuroimmunology, 261 (1-2). pp. 87-91.

Toland, A.E., Lin, R., Charlesworth, J., Stankovich, J., Perreau, V.M., Brown, M.A., Taylor, B.V. and Kermode, A.G. (2013) Identity-by-Descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. PloS one, 8 (3). e56379.

McAuliffe, W. and Kermode, A.G. (2013) Mystery of chronic cerebrospinal venous insufficiency: Identical venographic and ultrasound findings in patients with MS and controls. American Journal of Neuroradiology, 34 (7). pp. 1370-1374.

Seewann, A. and Kermode, A.G. (2013) Practical management of multiple sclerosis. Medicine Today, 14 (11). pp. 16-26.

Cortes, A., Field, J., Glazov, E.A., Hadler, J., Stankovich, J., Brown, M.A., Baxter, A., Kermode, A.G., Taylor, B., Booth, D.R., Mason, D., Stewart, G.J., Butzkueven, H., Charlesworth, J., Wiley, J., Lechner-Scott, J., Field, J., Tajouri, L., Griffiths, L., Slee, M., Brown, M.A., Moscato, P., Scott, R.J., Broadley, S., Vucic, S., Kilpatrick, T.J. and Carroll, W.M. (2013) Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. Human Molecular Genetics, 22 (11). pp. 2283-2292.

Musuka, T.D., Edis, R.H. and Kermode, A.G. (2013) Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing caused by a pituitary adenoma. Journal of Clinical Neuroscience, 20 (8). pp. 1180-1181.

Carroll, W., Saida, T., Kim, H., Kira, J., Kermode, A., Tsai, C., Fujihara, K., Kusunoki, S., Tanaka, M., Kim, K. and Bates, D. (2013) A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica). Multiple Sclerosis Journal, 19 (10). pp. 1371-1380.

Qiu, W., Pham, K., James, I., Nolan, D., Castley, A., Christiansen, F.T., Czarniak, P., Luo, Y., Wu, J., Garlepp, M., Wilton, S., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. Journal of Neuroimmunology, 261 (1-2). pp. 92-97.

Nolan, D., Castley, A., Tschochner, M., James, I., Qiu, W., Sayer, D., Christiansen, F.T., Witt, C., Mastaglia, F., Carroll, W. and Kermode, A. (2012) Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Neurology, 79 (6). pp. 538-546.

Qiu, W. and Kermode, A.G. (2011) Brain MRI in Neuromyelitis Optica: What is its Role? Current Neurology and Neuroscience Reports, 11 (6). pp. 526-528.

Ritchie, M.E., Liu, R., Carvalho, B.S., Irizarry, R.A. and Kermode, A.G. (2011) Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips. BMC Bioinformatics, 12 (1). p. 68.

Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C.C.A., Patsopoulos, N.A., Moutsianas, L., Dilthey, A., Su, Z., Freeman, C., Hunt, S.E., Edkins, S., Gray, E., Booth, D.R., Potter, S.C., Goris, A., Band, G., Bang Oturai, A., Strange, A., Saarela, J., Bellenguez, C., Fontaine, B., Gillman, M., Hemmer, B., Gwilliam, R., Zipp, F., Jayakumar, A., Martin, R., Leslie, S., Hawkins, S., Giannoulatou, E., D’alfonso, S., Blackburn, H., Martinelli Boneschi, F., Liddle, J., Harbo, H.F., Perez, M.L., Spurkland, A., Waller, M.J., Mycko, M.P., Ricketts, M., Comabella, M., Hammond, N., Kockum, I., McCann, O.T., Ban, M., Whittaker, P., Kemppinen, A., Weston, P., Hawkins, C., Widaa, S., Zajicek, J., Dronov, S., Robertson, N., Bumpstead, S.J., Barcellos, L.F., Ravindrarajah, R., Abraham, R., Alfredsson, L., Ardlie, K., Aubin, C., Baker, A., Baker, K., Baranzini, S.E., Bergamaschi, L., Bergamaschi, R., Bernstein, A., Berthele, A., Boggild, M., Bradfield, J.P., Brassat, D., Broadley, S.A., Buck, D., Butzkueven, H., Capra, R., Carroll, W.M., Cavalla, P., Celius, E.G., Cepok, S., Chiavacci, R., Clerget-Darpoux, F., Clysters, K., Comi, G., Cossburn, M., Cournu-Rebeix, I., Cox, M.B., Cozen, W., Cree, B.A.C., Cross, A.H., Cusi, D., Daly, M.J., Davis, E., de Bakker, P.I.W., Debouverie, M., D’hooghe, M.B., Dixon, K., Dobosi, R., Dubois, B., Ellinghaus, D., Elovaara, I., Esposito, F., Fontenille, C., Foote, S., Franke, A., Galimberti, D., Ghezzi, A., Glessner, J., Gomez, R., Gout, O., Graham, C., Grant, S.F.A., Rosa Guerini, F., Hakonarson, H., Hall, P., Hamsten, A., Hartung, H-P, Heard, R.N., Heath, S., Hobart, J., Hoshi, M., Infante-Duarte, C., Ingram, G., Ingram, W., Islam, T., Jagodic, M., Kabesch, M., Kermode, A.G., Kilpatrick, T.J., Kim, C., Klopp, N., Koivisto, K., Larsson, M., Lathrop, M., Lechner-Scott, J.S., Leone, M.A., Leppä, V., Liljedahl, U., Lima Bomfim, I., Lincoln, R.R., Link, J., Liu, J., Lorentzen, Å.R., Lupoli, S., Macciardi, F., Mack, T., Marriott, M., Martinelli, V., Mason, D., McCauley, J.L., Mentch, F., Mero, I-L, Mihalova, T., Montalban, X., Mottershead, J., Myhr, K-M, Naldi, P., Ollier, W., Page, A., Palotie, A., Pelletier, J., Piccio, L., Pickersgill, T., Piehl, F., Pobywajlo, S., Quach, H.L., Ramsay, P.P., Reunanen, M., Reynolds, R., Rioux, J.D., Rodegher, M., Roesner, S., Rubio, J.P., Rückert, I-M, Salvetti, M., Salvi, E., Santaniello, A., Schaefer, C.A., Schreiber, S., Schulze, C., Scott, R.J., Sellebjerg, F., Selmaj, K.W., Sexton, D., Shen, L., Simms-Acuna, B., Skidmore, S., Sleiman, P.M.A., Smestad, C., Sørensen, P.S., Søndergaard, H.B., Stankovich, J., Strange, R.C., Sulonen, A-M, Sundqvist, E., Syvänen, A-C, Taddeo, F., Taylor, B., Blackwell, J.M., Tienari, P., Bramon, E., Tourbah, A., Brown, M.A., Tronczynska, E., Casas, J.P., Tubridy, N., Corvin, A., Vickery, J., Jankowski, J., Villoslada, P., Markus, H.S., Wang, K., Mathew, C.G., Wason, J., Palmer, C.N.A., Wichmann, H-E, Plomin, R., Willoughby, E., Rautanen, A., Winkelmann, J., Wittig, M., Trembath, R.C., Yaouanq, J., Viswanathan, A.C., Zhang, H., Wood, N.W., Zuvich, R., Deloukas, P., Langford, C., Duncanson, A., Oksenberg, J.R., Pericak-Vance, M.A., Haines, J.L., Olsson, T., Hillert, J., Ivinson, A.J., De Jager, P.L., Peltonen, L., Stewart, G.J., Hafler, D.A., Hauser, S.L., McVean, G., Donnelly, P. and Compston, A. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476 (7359). pp. 214-219.

Patsopoulos, N.A., de Bakker, P.I.W. and Kermode, A.G. (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology, 70 (6). pp. 897-912.

Qiu, W., James, I., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2011) HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis. Multiple Sclerosis, 17 (4). pp. 382-388.

Qiu, W., Raven, S., Wu, J-S, Bundell, C., Hollingsworth, P., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2011) Hypothalamic lesions in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 82 (7). pp. 819-822.

Wang, J.H., Pappas, D., De Jager, P.L., Pelletier, D., de Bakker, P.I.W., Kappos, L., Polman, C.H., Chibnik, L.B., Hafler, D.A., Matthews, P.M., Hauser, S.L., Baranzini, S.E., Oksenberg, J.R. and Kermode, A.G. (2011) Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Medicine, 3 (1). p. 3.

Krahe, R., Ma, G.Z.M., Stankovich, J., Kilpatrick, T.J., Binder, M.D., Field, J. and Kermode, A.G. (2011) Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility. PloS one, 6 (2). e16964.

Qiu, W., Raven, S., James, I., Luo, Y., Wu, J., Castley, A., Christiansen, F.T., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2011) Spinal cord involvement in multiple sclerosis: A correlative MRI and high-resolution HLA-DRB1 genotyping study. Journal of the Neurological Sciences, 300 (1-2). pp. 114-119.

Qiu, W., Wu, J-S, Castley, A., James, I., Joseph, J., Christiansen, F.T., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia. Journal of Clinical Neuroscience, 17 (8). pp. 1009-1013.

Wu, J-S, James, I., Qiu, W., Castley, A., Christiansen, F.T., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. Journal of Neuroimmunology, 219 (1-2). pp. 109-113.

Wu, J.S., James, I., Wei, Q., Castley, A., Christiansen, F.T., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study. Multiple Sclerosis, 16 (5). pp. 526-532.

Qiu, W., Wu, J-S, Zhang, M-N, Matsushita, T., Kira, J-I, Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) Longitudinally extensive myelopathy in caucasians: A West Australian study of 26 cases from the Perth Demyelinating Diseases Database. Journal of Neurology, Neurosurgery & Psychiatry, 81 (2). pp. 209-212.

Qiu, W., Bundell, C., Wu, J.-S., Castley, A., James, I., Hollingsworth, P., Christiansen, F., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Multiple Sclerosis, 16 (3). pp. 351-354.

Wu, J-S, Qiu, W., Castley, A., James, I., Mastaglia, F.L., Christiansen, F.T, Carroll, W.M, Joseph, J. and Kermode, A.G. (2010) Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia. Multiple Sclerosis, 16 (1). pp. 15-20.

Jensen, C.J., Stankovich, J., Van der Walt, A., Bahlo, M., Taylor, B.V., van der Mei, I.A.F., Foote, S.J., Kilpatrick, T.J., Johnson, L.J., Wilkins, E., Field, J., Danoy, P., Brown, M.A., Rubio, J.P., Butzkueven, H. and Kermode, A.G. (2010) Multiple Sclerosis Susceptibility-Associated SNPs Do Not Influence Disease Severity Measures in a Cohort of Australian MS Patients. PloS one, 5 (4). e10003.

Field, J., Browning, S.R., Johnson, L.J., Danoy, P., Varney, M.D., Tait, B.D., Gandhi, K.S., Charlesworth, J.C., Heard, R.N., Stewart, G.J., Kilpatrick, T.J., Foote, S.J., Bahlo, M., Butzkueven, H., Wiley, J., Booth, D.R., Taylor, B.V., Brown, M.A., Rubio, J.P., Stankovich, J. and Kermode, A.G. (2010) A Polymorphism in the HLA-DPB1 Gene Is Associated with Susceptibility to Multiple Sclerosis. PloS one, 5 (10). e13454.

Wu, J-S, Qiu, W., Castley, A., James, I., Joseph, J., Christiansen, F.T., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. Journal of the Neurological Sciences, 288 (1-2). pp. 63-67.

Qiu, W., Raven, S., Wu, J-S, Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2010) Wedge-shaped medullary lesions in multiple sclerosis. Journal of the Neurological Sciences, 290 (1-2). pp. 190-193.

Gandhi, K.S., McKay, F.C., Cox, M., Riveros, C., Armstrong, N., Heard, R.N., Vucic, S., Williams, D.W., Stankovich, J., Brown, M., Danoy, P., Stewart, G.J., Broadley, S., Moscato, P., Lechner-Scott, J., Scott, R.J., Booth, D.R. and Kermode, A.G. (2010) The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Human Molecular Genetics, 19 (11). pp. 2134-2143.

Riveros, C., Mellor, D., Gandhi, K.S., McKay, F.C., Cox, M.B., Berretta, R., Vaezpour, S.Y., Inostroza-Ponta, M., Broadley, S.A., Heard, R.N., Vucic, S., Stewart, G.J., Williams, D.W., Scott, R.J., Lechner-Scott, J., Booth, D.R., Moscato, P. and Kermode, A.G. (2010) A transcription factor map as revealed by a Genome-wide gene expression analysis of Whole-Blood mRNA transcriptome in multiple sclerosis. PloS one, 5 (12). e14176.

Bahlo, M., Booth, D.R., Broadley, S.A., Brown, M.A., Foote, S.J., Griffiths, L.R., Kilpatrick, T.J., Lechner-Scott, J., Moscato, P., Perreau, V.M., Rubio, J.P., Scott, R.J., Stankovich, J., Stewart, G.J., Taylor, B.V., Wiley, J., Brown, M.A., Booth, D.R., Clarke, G., Cox, M.B., Csurhes, P.A., Danoy, P., Drysdale, K., Field, J., Foote, S.J., Greer, J.M., Griffiths, L.R., Guru, P., Hadler, J., McMorran, B.J., Jensen, C.J., Johnson, L.J., McCallum, R., Merriman, M., Merriman, T., Pryce, K., Scott, R.J., Stewart, G.J., Tajouri, L., Wilkins, E.J., Rubio, J.P., Bahlo, M., Brown, M.A., Browning, B.L., Browning, S.R., Perera, D., Rubio, J.P., Stankovich, J., Broadley, S., Butzkueven, H., Carroll, W.M., Chapman, C., Kermode, A.G., Marriott, M., Mason, D., Heard, R.N., Pender, M.P., Slee, M., Tubridy, N., Lechner-Scott, J., Taylor, B.V., Willoughby, E. and Kilpatrick, T.J. (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature Genetics, 41 (7). pp. 824-828.

Chong, H., Kira, J., Tsai, C., Ong, B., Li, P., Kermode, A. and Tan, C. (2009) Proposed modifications to the McDonald criteria for use in Asia. Multiple Sclerosis, 15 (7). pp. 887-888.

Qiu, W., Wu, J-S, Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2009) Wallenberg syndrome caused by multiple sclerosis mimicking stroke. Journal of Clinical Neuroscience, 16 (12). pp. 1700-1702.

Wu, J-S, Zhang, M-N, Carroll, W.M. and Kermode, A.G. (2008) Characterisation of the spectrum of demyelinating disease in Western Australia. Journal of Neurology, Neurosurgery & Psychiatry, 79 (9). pp. 1022-1026.

Thickbroom, G.W., Sacco, P., Faulkner, D.L., Kermode, A.G. and Mastaglia, F.L. (2008) Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis. Journal of Neurology, 255 (7). pp. 1001-1005.

Zhang, X., Wang, W., Wei, W., Wang, Q., Wei, Y. and Kermode, A.G. (2008) Etiological profile of presumptive optic neuritis in China. Journal of Clinical Neuroscience, 15 (12). pp. 1346-1349.

Grove, C.S., Robbins, P.D. and Kermode, A.G. (2008) Intravascular lymphoma presenting as progressive paraparesis. Journal of Clinical Neuroscience, 15 (9). pp. 1056-1058.

Kermode, A.G., Churchyard, A. and Carroll, W.M. (2008) Stroke complicating severe ovarian hyperstimulation syndrome. Australian and New Zealand Journal of Medicine, 23 (2). pp. 219-220.

Kho, L.K. and Kermode, A.G. (2007) Leflunomide-induced peripheral neuropathy. Journal of Clinical Neuroscience, 14 (2). pp. 179-181.

Kermode, A.G. (2006) 16 year long term follow-up data from the pivotal interferon beta-1b trial. Focus on Multiple Sclerosis, 2 . pp. 1-4.

Thickbroom, G.W., Sacco, P., Kermode, A.G., Archer, S.A., Byrnes, M.L., Guilfoyle, A. and Mastaglia, F.L. (2006) Central motor drive and perception of effort during fatigue in multiple sclerosis. Journal of Neurology, 253 (8). pp. 1048-1053.

Wong, S.H., Robbins, P.D., Knuckey, N.W. and Kermode, A.G. (2006) Cerebral amyloid angiopathy presenting with vasculitic pathology. Journal of Clinical Neuroscience, 13 (2). pp. 291-294.

Sutton, I. and Kermode, A.G. (2006) Hyperimmune goat serum (Aimspro®): Hope or hype? Journal of Clinical Neuroscience, 13 (10). pp. 1037-1038.

Thickbroom, G.W., Byrnes, M.L., Archer, S.A., Kermode, A.G. and Mastaglia, F.L. (2005) Corticomotor organisation and motor function in multiple sclerosis. Journal of Neurology, 252 (7). pp. 765-771.

Wong, S.H., Smith, D.W., Fallon, M.J. and Kermode, A.G. (2005) Murray valley encephalitis mimicking herpes simplex encephalitis. Journal of Clinical Neuroscience, 12 (7). pp. 822-824.

Leong, W.K. and Kermode, A.G. (2001) Acute deterioration in Chiari type 1 malformation after chiropractic cervical manipulation. Journal of Neurology, Neurosurgery & Psychiatry, 70 (6). pp. 816-817.

Holthouse, D.J. and Kermode, A. (1998) Non-toxigenic Corynebacterium diphtheriae: Two cases and review of the literature. Journal of Infection, 37 (1). pp. 62-66.

Kermode, A.G., Robbins, P.D. and Carroll, W.M. (1996) Cerebral lymphomatoid granulomatosis. Journal of Clinical Neuroscience, 3 (4). pp. 346-353.

Daenke, S., Kermode, A.G., Hall, S.E., Taylor, G., Weber, J., Nightingale, S. and Bangham, C.R.M. (1996) High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology, 217 (1). pp. 139-146.

Bangham, C.R.M., Kermode, A.G., Hall, S.E. and Daenke, S. (1996) The cytotoxic T-lymphocyte response to HTLV-I: the main determinant of disease? Seminars in Virology, 7 (1). pp. 41-48.

Kermode, A.G., Ives, F.J., Taylor, B., Davis, S.J. and Carroll, W.M. (1995) Progressive dural venous sinus thrombosis treated with local streptokinase infusion. Journal of Neurology, Neurosurgery & Psychiatry, 58 (1). pp. 107-108.

Nishimura, M., Kermode, A.G., Clerici, M., Shearer, G.M., Berzofsky, J.A., Uchiyama, T., Wiktor, S.Z., Pate, E., Maloney, B., Manns, A., Blattner, W. and Jacobson, S. (1994) Demonstration of Human T Lymphotropic Virus Type I (HTLV-I)-Specific T Cell Responses from Seronegative and Polymerase Chain Reaction-Negative Persons Exposed to HTLV-I. Journal of Infectious Diseases, 170 (2). pp. 334-338.

Kermode, A.G., Laing, B.A., Carroll, W.M. and Mastaglia, F.L. (1993) Immunoglobulin therapy. Neurology, 43 (12). p. 2727.

Thompson, A.J., Kermode, A.G., Moseley, I.F., MacManus, D.G. and McDonald, W.I. (1993) Seizures due to multiple sclerosis: Seven patients with MRI correlations. Journal of Neurology, Neurosurgery & Psychiatry, 56 (12). pp. 1317-1320.

Kermode, A.G., McNally, K.M. and Joyce, D.A. (1992) Sulphonylurea hypoglycaemic agents. The Medical Journal of Australia, 157 (10). pp. 717-720.

Kermode, A.G., Laing, B.A., Carroll, W.M. and Mastaglia, F.L. (1992) Intravenous immunoglobulin for multifocal motor neuropathy. The Lancet, 340 (8824). pp. 920-921.

Kermode, A.G., Day, T.J. and Carroll, W.M. (1992) Late radiation associated neurological injury. Clinical and Experimental Neurology, 29 . pp. 239-249.

Kermode, A.G., Chakera, T. and Mastaglia, F.L. (1992) Low osmolar and non-ionic X-ray contrast media and cortical blindness. Clinical and Experimental Neurology, 29 . pp. 272-276.

Plant, G.T., Kermode, A.G., Turano, G., Moseley, I. F., Miller, D.H., MacManus, D.G., Halliday, A.M. and McDonald, W.I. (1992) Symptomatic retrochiasmal lesions in multiple sclerosis: Clinical features, visual evoked potentials, and magnetic resonance imaging. Neurology, 42 (1). p. 68.

Cadoux-Hudson, T.A., Kermode, A., Rajagopalan, B., Taylor, D., Thompson, A.J., Ormerod, I.E., McDonald, W.I. and Radda, G.K. (1991) Biochemical changes within a multiple sclerosis plaque in vivo. Journal of Neurology, Neurosurgery & Psychiatry, 54 (11). pp. 1004-1006.

Youl, B.D., Kermode, A.G., Thompson, A.J., Revesz, T., Scaravilli, F., Barnard, R.O., Kirkham, F.J., Kendall, B.E., Kingsley, D. and Moseley, I.F. (1991) Destructive lesions in demyelinating disease. Journal of Neurology, Neurosurgery & Psychiatry, 54 (4). pp. 288-292.

Thompson, A.J., Kermode, A.G., Wicks, D., MacManus, D.G., Kendall, B.E., Kingsley, D.P.E. and McDonald, W.I. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Annals of Neurology, 29 (1). pp. 53-62.

Tofts, P.S. and Kermode, A.G. (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magnetic Resonance in Medicine, 17 (2). pp. 357-367.

Winer, J.B., Pires, M., Kermode, A., Ginsberg, L. and Rossor, M. (1991) Resolving MRI abnormalities with progression of subacute sclerosing panencephalitis. Neuroradiology, 33 (2). pp. 178-180.

Kermode, A.G., Thompson, A.J., Tofts, P.S., MacManus, D.G., Kendall, B.E., Kingsley, D.P.E., Moseley, I.F., Rudge, P. and McDonald, W.I. (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain, 113 (5). pp. 1477-1489.

Foster, G.R., Carmichael, D.J.S., Kermode, A., Hulme, B., Gabriel, J.R.T. and Cattell, V. (1990) Extensive crescent formation with antifibrinolytic therapy in a case of diffuse endocapillary glomerulonephritis. Nephrology Dialysis Transplantation, 5 (2). pp. 152-154.

Kermode, A.G., Tofts, P.S., Thompson, A.J., MacManus, D.G., Rudge, P., Kendall, B.E., Kingsley, D.P.E., Moseley, I. F., Du Boulay, E.P.G.H. and McDonald, W.I. (1990) Heterogeneity of blood-brain barrier changes in multiple sclerosis: An MRI study with gadolinium-DTPA enhancement. Neurology, 40 (2). p. 229.

Ormerod, I.E., Waddy, H.M., Kermode, A.G., Murray, N.M. and Thomas, P.K. (1990) Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: A clinical, electrophysiological and magnetic resonance imaging study. Journal of Neurology, Neurosurgery & Psychiatry, 53 (9). pp. 789-793.

Kermode, A.G., Rudge, P., Thompson, A.J., Du Boulay, E.P.G.H. and McDonald, W.I. (1990) MRI of thoracic cord in tropical spastic paraparesis. Journal of Neurology, Neurosurgery & Psychiatry, 53 (12). pp. 1110-1111.

Tofts, P.S., Kermode, A.G., MacManus, D.G. and Robinson, W.H. (1990) Nasal orientation device to control head movement during CT and MR studies. Journal of Computer Assisted Tomography, 14 (1). pp. 163-164.

Thompson, A.J., Kermode, A.G., MacManus, D.G., Kendall, B.E., Kingsley, D.P.E., Moseley, I.F. and McDonald, W.I. (1990) Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ, 300 (6725). pp. 631-634.

Tinker, R., Anderson, M.G., Anand, P., Kermode, A. and Harding, A.E. (1990) Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatraemia. Journal of Neurology, Neurosurgery & Psychiatry, 53 (1). pp. 87-88.

Kermode, A.G., Plant, G.T., MacManus, D.G., Kendall, B.E., Kingsley, D.P.E. and Moseley, I.F. (1989) Behçet's disease with slowly enlarging midbrain mass on MRI: resolution following steroid therapy. Neurology, 39 (9). pp. 1251-2.

Tofts, P.S. and Kermode, A.G. (1989) Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI. Journal of Neurology, Neurosurgery & Psychiatry, 52 (8). pp. 1019-1020.

Kermode, A.G. (1989) MRI in Behcet's disease. Journal of Neurology, Neurosurgery & Psychiatry, 52 (10). p. 1212.

Kermode, A.G., Moseley, I.F., Kendall, B.E., Miller, D.H., Macmanus, D.G. and McDonald, W.I. (1989) Magnetic resonance imaging in Leber's optic neuropathy. Journal of Neurology, Neurosurgery & Psychiatry, 52 (5). pp. 671-674.

Kermode, A., Boulay, E.D., Kendall, B., Kingsley, D., Moseley, I. and McDonald, W. (1989) Multiple sclerosis: Correlation of magnetic resonance imaging with cerebrospinal fluid findings. Journal of Neurology, Neurosurgery & Psychiatry, 52 (1). pp. 144-145.

Thompson, A.J., Kermode, A.G., MacManus, D.G., Kingsley, D.P.E., Kendall, B.E., Moseley, I.F. and McDonald, W.I. (1989) Pathogenesis of progressive multiple sclerosis. The Lancet, 333 (8650). pp. 1322-1323.

Plant, G.T., Kermode, A.G., Du Boulay, E.P.G.H. and McDonald, W.I. (1989) Spasmodic torticollis due to a midbrain lesion in a case of multiple sclerosis. Movement Disorders, 4 (4). pp. 359-362.

Kermode, A.G., Plant, G.T., Miller, D.H., Kendall, B.E. and McDonald, W.I. (1989) Tobacco-alcohol amblyopia: Magnetic resonance imaging findings. Journal of Neurology, Neurosurgery & Psychiatry, 52 (12). p. 1447.

Kermode, A.G., Tofts, P.S., Macmanus, D.G., Kendall, B.E., Kingsley, D.P.E., Moseley, I.F., Du Boulay, E.P.G.H. and McDonald, W.I. (1988) Early lesion of multiple sclerosis. The Lancet, 332 (8621). pp. 1203-1204.

Conference Paper

Barnes, D., Hawkins, C.P., Kermode, A.G. and McDonald, W.I. (1990) MRI studies relevant to the pathology and pathogenesis of MS. In: XIth International Congress of Neuropathology, 2 - 8 September 1990, Kyoto, Japan

Conference Item

Tschochner, M., Strautins, K., James, I., Leary, S., Choo, L., Clark, H., Dunn, D., Chopra, A., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2016) Contribution of EBV infection to Multiple Sclerosis Pathogenesis: Human leukocyte antigen restricted, EBV epitope-specific T cell responses in Multiple Sclerosis. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Kermode, A. (2016) Early treatment of MS. In: 15th Asian and Oceanian Congress of Neurology (AOCN), 18 - 21 August 2016, Kuala Lumpur, Malaysia.

Strautins, K., Tschochner, M., Berry, C., James, I., Leary, S., Choo, L., Clark, H., Pedrini, M., Kermode, A., Carroll, W. and Nolan, D. (2016) Identifying novel potential cross-reactive targets in Multiple Sclerosis. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Kermode, A. (2016) Is there such a thing as benign MS? In: Australian and New Zealand Association of Neurologists (ANZAN) Annual Scientific Meeting, 24 - 27 May 2016, Perth, WA.

Chang, Y., Huang, Q., Wang, Y., Sun, X., Yi, S., Bei, J., Peng, L., Hu, X., Kermode, A. and Qiu, W. (2016) Whole exome sequencing in a Chinese family with neuromyelitis optica spectrum disorder. In: 9th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2016, 27 - 29 October 2016, Bangkok, Thailand.

Strautins, K., Tschochner, M., James, I., Leary, S., Choo, L., Walters, S., Pedrini, M., Dunn, D., Berry, C., Clark, H., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2015) Investigating the role of EBV infection in multiple sclerosis pathogenesis. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Kermode, A.G. (2014) Controversies in NMO. In: 55th Annual Meeting of the Japanese Society of Neurology, 21 - 24 May 2014, Fukuoka, Japan.

Kermode, A.G. (2014) Grey matter and MS: 50 Shades of Grey. In: Novartis Clinical Neurology Symposium, 8 - 9 March 2014, Sydney, NSW.

Kermode, A.G. (2014) Moving beyond conventional markers of Disease Activity to Evaluate MS Progression. In: 7th Annual Meeting PACTRIMS, 6 - 8 November 2014, Taipei, Taiwan.

Kermode, A.G. (2014) Multiple Sclerosis Update. In: RACGP Update. St John of God Hospital, 15 July 2014, Subiaco, WA.

Kermode, A.G. (2014) Natalizumab in real clinical practice. In: 55th Annual Meeting of the Japanese Society of Neurology, 21 - 24 May 2014, Fukuoka, Japan.

Kermode, A.G. (2014) What is new in Multiple Sclerosis. In: An Eye on Inflammation Inaugural Annual Grand Round, 30 July 2014, Harry Perkins Institute, Nedlands.

Pedrini, M.J., Seewann, A., Bennett, K.A., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2013) Asymptomatic course and resolution of PML during Natalizumab therapy with pre-emptive treatment for IRIS. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pedrini, M.J., Xu, W., Xu, Z., Seewann, A., Burton, J., Carroll, W.M. and Kermode, A.G. (2013) Benign multiple sclerosis: A longitudinal follow-up study of large Western Australian cohort. In: European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) 2013, 2 - 5 October 2013, Copenhagen, Denmark.

Pedrini, M.J., Xu, W., Xu, Z., Carroll, W.M. and Kermode, A.G. (2013) Benign multiple sclerosis: A longitudinal follow-up study of large Western Australian cohort. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pedrini, M.J., Xu, W., Xu, Z., Carroll, W.M. and Kermode, A.G. (2013) Benign multiple sclerosis: A longitudinal follow-up study of large Western Australian cohort. In: MS Research Conference, 14 - 15 November 2013, Melbourne, VIC.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D.S., Pedrini, M. and Kermode, A. (2013) Combining genetic risk factors, gender And Anti-Epstein Barr Virus (EBV) antibody profiles, sing A Novel Anti-EBV Nuclear Antigen-1 (EBNA-1) B Cell Epitope ELISA, to stratify multiple sclerosis risk. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Kermode, A. (2013) Current understanding of pathogenic mechanisms for MS and a novel therapeutic approach. In: Multiple Sclerosis for Healthcare Professionals conference, 14 - 15 September 2013, Sydney, NSW.

Kermode, A., Pedrini, M., Seewann, A., Bennet, K., Marshall, B. and Carroll, W. (2013) Helicobacter pylori infection as a protective factor against multiple sclerosis development in Western Australians. In: European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) 2013, 2 - 5 October 2013, Copenhagen, Denmark.

Pedrini, M.J., Seewann, A., Bennett, K.A., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2013) Helicobacter pylori infection as a protective factor against multiple sclerosis development in Western Australians. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Kermode, A.G. (2013) How recently identified MS genes may affect clinical practice. In: Where MS Research and Clinical Practice Meet, 25 November 2013, University Club of Western Australia, Perth.

Tschochner, M., Leary, S., Strautins, K., Clark, H., Chopra, A., Choo, L., Carroll, W., Kermode, A. and Nolan, D. (2013) Identifying Epstein-Barr virus EBNA-1 sequence variation using 454 FLX technology in Multiple Sclerosis patient samples. In: Keystone Symposia on Molecular and Cellular Biology: Multiple Sclerosis, 11 - 16 January 2013, Big Sky, Montana USA.

Kermode, A.G. (2013) Immunotherapy, sex and the whole damn thing. In: Multiple Sclerosis Nurses Association Annual Scientific Meeting, 6 September 2013, Perth, WA.

Kermode, A.G. (2013) Multiple Sclerosis Controversies. In: Australian Society of Immunology and Allergy, Annual Scientific Meeting, 13 September 2013, Perth, WA.

Tschochner, M., Leary, S., Strautins, K., Clark, H., Cooper, D., Chopra, A., Choo, L., Carroll, W., Kermode, A. and Nolan, D. (2013) Multiple Sclerosis Patient Sequence Variation In Epstein-Barr Virus Nuclear Antigen 1. In: Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2013, 6 - 8 November 2013, Kyoto, Japan.

Kermode, A.G. (2013) Multiple Sclerosis: Fact and Fiction. In: RACGP Future Directions in Health Congress 2013, 27 May 2013, Perth, WA.

Kermode, A.G. (2013) Spasticity: A potentially disabling and frequent symptom in MS. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Kermode, A.G. (2013) Treatment for the active MS patient: Benefits and risks of Natalizumab use. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Castley, A., Tschochner, M., James, I., Kermode, A., Carroll, W., Sayer, D., Christiansen, F., Witt, C. and Nolan, D. (2011) Investigation of promoter HLA-DRB1 polymorphism in relation to a putative VDRE motif: HLA-DRB1 allele associations and influence on risk of multiple sclerosis. In: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, 19 – 22 October 2011, Amsterdam, Netherlands.

Wu, J., Qui, W., James, I., Joseph, J., Carroll, W., Christiansen, F., Mastaglia, F. and Kermode, A. (2009) Frequency of HLA-DRB1 alleles and disease-modifying effects in a large West Australian multiple sclerosis cohort. In: Australian & New Zealand Association of Neurologists Annual Scientific Meeting, 18 - 21 May 2009, Christchurch, New Zealand.

Book Chapter

Kermode, A.G., Tofts, P.S., Thompson, A.J., Rudge, P., MacManus, D.G., Kendall, B.E., Moseley, I.F., Kingsley, D.P.E. and McDonald, W.I. (1989) Changing activity in MS lesions: An MRI study. In: Gonsette, R.E. and Delmotte, P., (eds.) Recent Advances in Multiple Sclerosis Therapy (Volume 863 of International Congress Series). Excepta Medica Communications, pp. 43-46.

This list was generated on Sun May 19 06:47:09 2019 UTC.